BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27661973)

  • 1. Prognostic Significance of Hemodynamic and Clinical Stages in the Prediction of Hepatocellular Carcinoma.
    Suk KT; Kim EJ; Kim DJ; Kim HS; Bang CS; Park TY; Baik GH; Kim SE; Park JW; Park SH; Lee MS; Kim HS; Jang MK; Park SH; Choi E; Kim CH; Sung H; Park CK
    J Clin Gastroenterol; 2017 Mar; 51(3):285-293. PubMed ID: 27661973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
    Giannini EG; Marenco S; Borgonovo G; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Anna Di Nolfo M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Hepatology; 2012 Oct; 56(4):1371-9. PubMed ID: 22535689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma.
    Tsai JF; Jeng JE; Chuang LY; You HL; Wang LY; Hsieh MY; Chen SC; Chuang WL; Lin ZY; Yu ML; Dai CY
    Scand J Gastroenterol; 2005 Jan; 40(1):68-75. PubMed ID: 15841717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients.
    Kim TY; Suk KT; Jeong SW; Ryu T; Kim DJ; Baik SK; Sohn JH; Jeong WK; Choi E; Jang JY; Kim MY
    J Korean Med Sci; 2019 Aug; 34(33):e223. PubMed ID: 31436052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis.
    Kim TY; Lee JG; Sohn JH; Kim JY; Kim SM; Kim J; Jeong WK
    Yonsei Med J; 2016 Jan; 57(1):138-45. PubMed ID: 26632394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good performance of liver stiffness measurement in the prediction of postoperative hepatic decompensation in patients with cirrhosis complicated with hepatocellular carcinoma.
    Procopet B; Fischer P; Horhat A; Mois E; Stefanescu H; Comsa M; Graur F; Bartos A; Lupsor-Platon M; Badea R; Grigorescu M; Tantau M; Sparchez Z; Al Hajjar N
    Med Ultrason; 2018 Aug; 20(3):272-277. PubMed ID: 30167578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
    Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
    Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
    Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
    World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.
    Gómez-Rodríguez R; Romero-Gutiérrez M; Artaza-Varasa T; González-Frutos C; Ciampi-Dopazo JJ; de-la-Cruz-Pérez G; Sánchez-Ruano JJ
    Rev Esp Enferm Dig; 2012 Jun; 104(6):298-304. PubMed ID: 22738699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 11. HVPG signature: A prognostic and predictive tool in hepatocellular carcinoma.
    Qi X; Zhang X; Li Z; Hui J; Xiang Y; Chen J; Zhao J; Li J; Qi FZ; Xu Y
    Oncotarget; 2016 Sep; 7(38):62789-62796. PubMed ID: 27566593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography.
    Pérez-Latorre L; Sánchez-Conde M; Rincón D; Miralles P; Aldámiz-Echevarría T; Carrero A; Tejerina F; Díez C; Bellón JM; Bañares R; Berenguer J
    Clin Infect Dis; 2014 Mar; 58(5):713-8. PubMed ID: 24265358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irregularity of parenchymal echo patterns of liver analyzed with a neural network and risk of hepatocellular carcinoma in liver cirrhosis.
    Fukuda H; Ebara M; Kobayashi A; Sugiura N; Yoshikawa M; Saisho H; Kato K; Kondo F; Yahagi T
    Oncology; 2002; 63(3):270-9. PubMed ID: 12381907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.
    Ripoll C; Groszmann RJ; Garcia-Tsao G; Bosch J; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS;
    J Hepatol; 2009 May; 50(5):923-8. PubMed ID: 19303163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
    Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H
    Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive Tests for Fibrosis Predict 5-Year Mortality and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Kim JH; Kim JW; Seo JW; Choe WH; Kwon SY
    J Clin Gastroenterol; 2016; 50(10):882-888. PubMed ID: 27322532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis].
    Lee SH; Park SH; Kim GW; Lee WJ; Hong WK; Ryu MS; Park KT; Lee MY; Lee CW; Kim JH; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
    Korean J Hepatol; 2009 Sep; 15(3):350-6. PubMed ID: 19783884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.